Document is current
Any future updates will be listed below
-
Authors
Chen, Li Juen
Plantinga, Anna M.
Burr, Robert
Cain, Kevin
Barney, Pamela
Savidge, Tor
Shulman, Robert J.
Heitkemper, Margaret
Kamp, Kendra
-
Funding
Funding for this research was provided by:
National Institute of Nursing Research (R01NR014479, K23NR020044)
- License Information
-
More Information
Article History
Received: 28 August 2024
Accepted: 26 December 2024
First Online: 8 January 2025
Declarations
:
: TS is an inventor on patent applications (PCT/US2019/051950 and P0359US.P1) covering methods to diagnose diarrheal disease using stool microbiome biomarkers. TS received research funding from Merck, Nivalis, Cubist, Mead Johnson, Rebiotix, BioFire, and Assembly BioSciences and has served on the advisory board for Rebiotix and BioFire.
: This study was performed in line with principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of the University of Washington.
: Informed consent was obtained from all individual participants included in the study.
